P. Holm et al., THE ENDOTHELIN ANTAGONIST BOSENTAN - HEMODYNAMIC-EFFECTS DURING NORMOXIA AND HYPOXIA PULMONARY-HYPERTENSION IN PIGS, Journal of thoracic and cardiovascular surgery, 112(4), 1996, pp. 890-897
In this study, we investigated the hemodynamic effects and receptor-bl
ocking properties of the nonselective endothelin antagonist bosentan i
n pigs during normoxia and acute hypoxia. Hypoxic pulmonary hypertensi
on was induced by decreasing the fraction of inhaled oxygen to 0.1, Tn
a control group of pigs, hemodynamic parameters proved to be stable t
hrough 2 hours of hypoxia. Infusions of endothelin-1, endothelin-3, an
d sarafotoxin 6c into the pulmonary artery resulted in pulmonary and s
ystemic vasoconstriction during normoxia. whereas endothelin administr
ation during hypoxic pulmonary hypertension resulted in pulmonary vaso
dilation. After administration of bosentan, the vasopressor effect of
endothelin-1 during normoxia was significantly attenuated and the pulm
onary vasodilatory effect of endothelin-1 during hypoxia was reduced,
Furthermore, the development of hypoxic pulmonary hypertension was sig
nificantly reduced by bosentan, In contrast, bosentan did not influenc
e the pulmonary vasopressor response to the thromboxane mimic U-46619.
We therefore conclude that vasopressor endothelin receptors seem to b
e activated by endogenous endothelin released during hypoxia, leading
to an increase in the pulmonary vascular tone.